SB-203580 , ≥98%(HPLC) , 152121-47-6
Synonym(s):
4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole;4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole, p38 MAP Kinase Inhibitor XVI;SB 203580 - CAS 152121-47-6 - Calbiochem
CAS NO.:152121-47-6
Empirical Formula: C21H16FN3OS
Molecular Weight: 377.43
MDL number: MFCD00922198
Pack Size | Price | Stock | Quantity |
5MG | RMB79.20 | In Stock |
|
25MG | RMB239.20 | In Stock |
|
100MG | RMB719.20 | In Stock |
|
500MG | RMB2639.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 144-146 |
Boiling point: | 615.6±55.0 °C(Predicted) |
Density | 1.4 |
storage temp. | -20°C |
solubility | DMSO: 50 mg/mL |
form | solid |
pka | 9.60±0.10(Predicted) |
color | white to off-white |
Stability: | -200C |
InChIKey | CDMGBJANTYXAIV-UHFFFAOYSA-N |
CAS DataBase Reference | 152121-47-6(CAS DataBase Reference) |
Description and Uses
SB 203580 (152121-47-6) is a potent and selective inhibitor of p38 MAP kinase, IC50=50 and 500 nM for p38 and p38β2 respectively.1 No other kinases (in a panel of 30) were significantly inhibited including p38γ and δ at 10 μM.2?A potent inhibitor of inflammatory cytokine production (IC50=15-25 mg/kg in mice and rats) in animal models of arthritis, bone resorption, endotoxin shock and immune function.3
MDCK cells were treated with SB 203580 to study the role of MAPK signaling in inducing hypertonicity of cell membrane and potassium depletion.16 It was used to inhibit MAPK signaling in mouse cortical neurons17 and human hepatocellular carcinoma cell lines.18
Safety
Symbol(GHS) | GHS05,GHS07 |
Signal word | Danger |
Hazard statements | H302-H318 |
Precautionary statements | P264-P270-P280-P301+P312-P305+P351+P338-P501 |
Hazard Codes | Xn |
Risk Statements | 22-41 |
Safety Statements | 26-39 |
WGK Germany | 3 |
HS Code | 29333990 |